Details of the Drug

General Information of Drug (ID: DMAO869)

• Drug Name: AGN-214868
• Synonyms: SXN-100323; SXN-323; Cell secretion inhibitors (pain), Syntaxin/Allergan; Modified bacterial protein therapies (pain), Allergan/Syntaxin; Clostridial endopeptidase-based compounds (pain), Allergan/Syntaxin; Neurotoxin-based technology (pain), CAMR/Allergan

Indication

Disease Entry	ICD 11	Status	REF
Overactive bladder	GC50.0	Phase 2	[1]

• Cross-matching ID: TTD ID: D02PNP

References

• [1] ClinicalTrials.gov (NCT01678924) A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia. U.S. National Institutes of Health.